Apellis and Beam Therapeutics Enter Exclusive Research Collaboration to Apply Base Editing to…
Apellis Pharmaceuticals, Inc. and Beam Therapeutics Inc. announced an exclusive five-year research collaboration focused on the use of Beam’s proprietary base editing technology to…
Read More...
Read More...